ATRY.MC BME
Atrys Health, S.A.
1W: -4.8%
1M: +3.2%
3M: +0.4%
YTD: -12.5%
1Y: -9.2%
3Y: -42.3%
5Y: -76.0%
€2.54 ($2.84)
-0.04 (-1.36%)
Weekly Expected Move ±5.8%
€2
€2
€3
€3
€3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$3M
-47.4% ▼
5Y CAGR: +22.6%
Capital Expenditures
$13M
-110.3% ▼
5Y CAGR: +22.3%
Free Cash Flow
-$10M
-1753.9% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$27K
+0.0% ▲
Net Change in Cash
-$21M
-384.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1M | -$23M | -$25M | -$34M | -$33M |
| Depreciation & Amort. | $4M | $21M | $30M | $30M | $29M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$4M | $16K | -$14M | -$1M | -$7M |
| Other Non-Cash Items | -$254K | $7M | -$7M | $4M | $14M |
| Operating Cash Flow | -$1M | $5M | -$15M | -$1M | $3M |
| — Investing Activities — | |||||
| Capital Expenditures | -$5M | -$9M | -$15M | -$6M | -$13M |
| Acquisitions (Net) | -$47M | -$11M | -$76M | $16M | $0 |
| Investment Purchases | -$71K | -$1M | -$4M | -$2M | -$200K |
| Investment Sales | $2M | $12M | -$8M | $0 | $143K |
| Other Investing | -$2M | $6M | $22M | -$7M | $242K |
| Investing Cash Flow | -$52M | -$2M | -$81M | $395K | -$13M |
| — Financing Activities — | |||||
| Net Debt Issuance | $27M | $14M | $20M | $12M | -$15M |
| Stock Repurchased | $0 | -$120K | $0 | $0 | -$27K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $880K | $0 | -$8M | -$4M | $3M |
| Financing Cash Flow | $63M | $14M | $95M | $8M | -$12M |
| Net Change in Cash | $9M | $18M | -$831K | $8M | -$21M |
| Cash End of Period | $17M | $35M | $34M | $42M | $20M |
| Free Cash Flow | -$7M | -$4M | -$31M | -$547K | -$10M |